Macular lesions during systemic therapy with depot tetracosactrin.
作者信息
Williamson J, Nuki G
出版信息
Br J Ophthalmol. 1970 Jun;54(6):405-9. doi: 10.1136/bjo.54.6.405.
Abstract
摘要
相似文献
1
Macular lesions during systemic therapy with depot tetracosactrin.
Br J Ophthalmol. 1970 Jun;54(6):405-9. doi: 10.1136/bjo.54.6.405.
2
Posterior subcapsular cataracts and macular lesions after long-term corticotrophin therapy.
Br J Ophthalmol. 1967 Dec;51(12):839-42. doi: 10.1136/bjo.51.12.839.
3
[Oculo-neuro-myopathic syndrome due to chloroquine intoxication].
Rhumatologie. 1969 Apr;21(4):123-5.
4
Intermittent tetracosactrin-depot therapy in dermatology.
Br J Dermatol. 1970 Apr;82(4):389-96. doi: 10.1111/j.1365-2133.1970.tb06838.x.
5
Tetracosactrin in the treatment of rheumatic diseases.
Med J Aust. 1972 Jun 10;1(24):1271.
6
Tetracosactrin in the treatment of rheumatic diseases.
Med J Aust. 1972 Jul 1;2(1):52-3.
7
Tetracosactrin in the treatment of rheumatic diseases.
Med J Aust. 1972 Jul 29;2(5):282-3.
8
Fundus flavimaculatus. Two familial cases with macular degeneration.
Br J Ophthalmol. 1968 Nov;52(11):849-52. doi: 10.1136/bjo.52.11.849.
9
[Technic of residual vision training in cases of macular degeneration].
Klin Monbl Augenheilkd. 1973 Apr;162(4):550-3.
10
Leucocytosis after tetracosactrin.
Br Med J. 1972 Oct 21;4(5833):178. doi: 10.1136/bmj.4.5833.178-b.
引用本文的文献
1
Circadian disturbance and idiopathic central serous chorioretinopathy.
Graefes Arch Clin Exp Ophthalmol. 2016 Nov;254(11):2175-2181. doi: 10.1007/s00417-016-3378-y. Epub 2016 May 21.
2
Central serous chorioretinopathy: update on pathophysiology and treatment.
Surv Ophthalmol. 2013 Mar-Apr;58(2):103-26. doi: 10.1016/j.survophthal.2012.07.004.
3
Central serous retinopathy associated with adrenocorticotrophic hormone therapy. A case report and a hypothesis.
Graefes Arch Clin Exp Ophthalmol. 1997 Jun;235(6):339-44. doi: 10.1007/BF00937280.
4
Diffuse retinal pigment epitheliopathy complicating systemic corticosteroid treatment.
Br J Ophthalmol. 1995 Oct;79(10):922-5. doi: 10.1136/bjo.79.10.922.
5
Central serous chorioretinopathy complicating systemic corticosteroid treatment.
Br J Ophthalmol. 1984 May;68(5):329-31. doi: 10.1136/bjo.68.5.329.
6
Six cases of central serous choroidopathy induced by systemic corticosteroid therapy.
Doc Ophthalmol. 1985 Aug 15;60(1):37-44. doi: 10.1007/BF00164568.
7
Type A behavior and central serous chorioretinopathy.
Trans Am Ophthalmol Soc. 1986;84:799-845.
8
Serous retinal detachment resembling central serous chorioretinopathy following organ transplantation.
Graefes Arch Clin Exp Ophthalmol. 1990;228(4):305-9. doi: 10.1007/BF00920052.
本文引用的文献
1
Adverse Reactions to Corticosteroid Therapy in the Eye.
Proc R Soc Med. 1965 Jul;58(7):533-5. doi: 10.1177/003591576505800724.
2
CHANGES IN THE INTRAOCULAR PRESSURE ASSOCIATED WITH SYSTEMIC STEROID THERAPY.
Am J Ophthalmol. 1963 Aug;56:245-7. doi: 10.1016/0002-9394(63)91858-0.
3
Antinucleolar antibodies.
Lancet. 1962 Sep 22;2(7256):575-7. doi: 10.1016/s0140-6736(62)90446-4.
4
Maculopathy a corticosteroid side-effect.
J All India Ophthalmol Soc. 1966 Dec;14(6):250-2.
5
Steroid cataract.
Ann Rheum Dis. 1966 Jul;25(4):364-8. doi: 10.1136/ard.25.4.364.
6
Effect of systemically administered corticosteroids on intraocular pressure and fluid dynamics.
Acta Ophthalmol (Copenh). 1965;43(4):524-7. doi: 10.1111/j.1755-3768.1965.tb03687.x.
Zotero 插件